World's Best Scientists 2026 revealed!
Wiley A. Schell

Wiley A. Schell

D-Index & Metrics

Microbiology

D-Index
49
Citations
8568
World Ranking
4572
National Ranking
1767

Overview

Wiley A. Schell is affiliated with Duke University in the United States and specializes in the field of Medicine, with a focus on Epidemiology, Infectious Diseases, Organic Chemistry, Genetics, and Pulmonary and Respiratory Medicine. Their work encompasses a range of topics including fungal infections and studies, antifungal resistance and susceptibility, nail diseases and treatments, chronic lymphocytic leukemia research, synthesis and biological activity, respiratory and cough-related research, as well as cutaneous lymphoproliferative disorders research.

Recent publications by Wiley A. Schell demonstrate a concentration on fungal infections and antifungal therapies. Notable papers include:

  • Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis (2022) published in mBio
  • Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase Inhibition (2023) in Infection and Immunity
  • A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infection (2024) in mBio
  • Black mold takes hold and story told (2020) in Medical Mycology Case Reports
  • Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis (2023) in Antimicrobial Agents and Chemotherapy

Wiley A. Schell has frequently published in several venues, primarily:

  • mBio
  • Open Forum Infectious Diseases
  • UNC Libraries
  • Infection and Immunity
  • Medical Mycology Case Reports

Collaboration is evident through recurring co-authorship with a number of researchers, including:

  • John R. Perfect (9 publications)
  • Charles Giamberardino (6 publications)
  • Jennifer L. Tenor (6 publications)
  • Dena L. Toffaletti (6 publications)
  • Julia R. Palmucci (4 publications)

The scientist's research is marked by contributions to fungal infection studies and antifungal susceptibility, reflected in consistent output over recent years. Their interdisciplinary approach draws upon expertise in epidemiology and organic chemistry to address challenges in infectious diseases, which is supported by a diverse publication record and multiple collaborative relationships.

Best Publications

  • Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

    Leah E. Cowen;Sheena D. Singh;Julia R. Köhler;Cathy Collins

  • Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

    Sheena D. Singh;Nicole Robbins;Aimee K. Zaas;Wiley A. Schell

  • PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90

    Shantelle L. LaFayette;Cathy Collins;Aimee K. Zaas;Wiley A. Schell

  • Multiplexed Real-Time Polymerase Chain Reaction on a Digital Microfluidic Platform

    Zhishan Hua;Jeremy L. Rouse;Allen E. Eckhardt;Vijay Srinivasan

  • The New Fungal Opportunists Are Coming

    John R. Perfect;Wiley A. Schell

  • Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents

    Maurizio Del Poeta;Wiley A. Schell;Christine C. Dykstra;Susan Jones

  • Preserving accuracy in GenBank

    Thomas D. Bruns;Meredith Blackwell;Ivan Edwards;Andy F.S. Taylor

  • Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology

    Katharine Liu;David N. Howell;David N. Howell;John R. Perfect;John R. Perfect;Wiley A. Schell;Wiley A. Schell

  • Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence

    Jill R. Blankenship;Floyd L. Wormley;Molly K. Boyce;Wiley A. Schell

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    A. Espinel-Ingroff;A.I. Aller;E. Canton;L.R. Castanon-Olivares

  • In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.

    M Del Poeta;W A Schell;J R Perfect

  • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

    M L Cameron;W A Schell;S Bruch;J A Bartlett

  • Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agents

    Chad E. Stephens;Farial Tanious;Susan Kim;W. David Wilson

  • Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

    Frank C. Odds;Mary Motyl;Roberto Andrade;Jacques Bille

  • Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

    Aimee K. Zaas;Molly Boyce;Wiley Schell;Barbara Alexander Lodge

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

    A. Espinel-Ingroff;A. Chowdhary;M. Cuenca-Estrella;A. Fothergill

  • Quantitation of Candida CFU in Initial Positive Blood Cultures

    Christopher D. Pfeiffer;Gregory P. Samsa;Wiley A. Schell;L. Barth Reller

  • In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.

    J R Perfect;G M Cox;R K Dodge;W A Schell

  • In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.

    William J. Steinbach;Wiley A. Schell;Jill R. Blankenship;Chiatogu Onyewu

  • Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans.

    Takuya Miwa;Yukinobu Takagi;Makiko Shinozaki;Cheol Won Yun

  • Preserving accuracy in GenBank

    M. I. Bidartondo;Thomas D. Bruns;Meredith Blackwell;Ivan Edwards

Frequent Co-Authors

John R. Perfect
John R. Perfect Duke University
Barbara D. Alexander
Barbara D. Alexander Duke University
William J. Steinbach
William J. Steinbach Duke University
Daniel K. Benjamin
Daniel K. Benjamin Duke University
Luis Ostrosky-Zeichner
Luis Ostrosky-Zeichner The University of Texas Health Science Center at Houston
Josep Guarro
Josep Guarro Rovira i Virgili University
John D. Turnidge
John D. Turnidge University of Adelaide
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
M. Catherine Aime
M. Catherine Aime Purdue University West Lafayette
Joseph Heitman
Joseph Heitman Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career paths in healthcare and beyond. For those interested in combining clinical knowledge with patient care, becoming a functional medicine np salary is an attractive option offering rewarding work and competitive compensation.

Alternatively, careers in medical coding and health data management are rapidly growing fields. Earning certification as a certified professional coder (cpc) provides specialized skills essential for ensuring accuracy in medical billing and coding processes.

For a broader scope in healthcare administration, pursuing a bachelor of science in health information management salary can lead to dynamic roles managing patient data and healthcare systems.

Many students prefer flexible learning through online health information management programs cahiim accredited, which provide recognized credentials and practical expertise needed to excel in this evolving sector.

Best Scientists Citing Wiley A. Schell

Trending Scientists

Recently Published Articles